CN111527067A - Method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethylamine monofumarate - Google Patents
Method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethylamine monofumarate Download PDFInfo
- Publication number
- CN111527067A CN111527067A CN201880082979.8A CN201880082979A CN111527067A CN 111527067 A CN111527067 A CN 111527067A CN 201880082979 A CN201880082979 A CN 201880082979A CN 111527067 A CN111527067 A CN 111527067A
- Authority
- CN
- China
- Prior art keywords
- pyrrole
- fluorophenyl
- compound
- represented
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 47
- ROGSHYHKHPCCJW-WLHGVMLRSA-N (e)-but-2-enedioic acid;1-[5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrol-3-yl]-n-methylmethanamine Chemical compound OC(=O)\C=C\C(O)=O.C=1C=CN=CC=1S(=O)(=O)N1C=C(CNC)C=C1C1=CC=CC=C1F ROGSHYHKHPCCJW-WLHGVMLRSA-N 0.000 title abstract description 11
- MQULPEUCGKEHEG-UHFFFAOYSA-N 5-(2-fluorophenyl)-1h-pyrrole-3-carbaldehyde Chemical compound FC1=CC=CC=C1C1=CC(C=O)=CN1 MQULPEUCGKEHEG-UHFFFAOYSA-N 0.000 claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims description 54
- -1 N-protected pyrrole Chemical class 0.000 claims description 36
- 125000006239 protecting group Chemical group 0.000 claims description 35
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical group [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims description 19
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 18
- 239000003054 catalyst Substances 0.000 claims description 17
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 11
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 239000002184 metal Substances 0.000 claims description 11
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 9
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims description 8
- 229910052763 palladium Inorganic materials 0.000 claims description 8
- 150000003233 pyrroles Chemical class 0.000 claims description 8
- CHNYVNOFAWYUEG-UHFFFAOYSA-N 1h-pyrrole-3-carbaldehyde Chemical class O=CC=1C=CNC=1 CHNYVNOFAWYUEG-UHFFFAOYSA-N 0.000 claims description 7
- CDRNYKLYADJTMN-UHFFFAOYSA-N pyridine-3-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CN=C1 CDRNYKLYADJTMN-UHFFFAOYSA-N 0.000 claims description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 5
- 125000000025 triisopropylsilyl group Chemical group C(C)(C)[Si](C(C)C)(C(C)C)* 0.000 claims description 5
- 239000001530 fumaric acid Substances 0.000 claims description 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 4
- BFDBKMOZYNOTPK-UHFFFAOYSA-N vonoprazan Chemical compound C=1C=CN=CC=1S(=O)(=O)N1C=C(CNC)C=C1C1=CC=CC=C1F BFDBKMOZYNOTPK-UHFFFAOYSA-N 0.000 claims description 4
- 150000007529 inorganic bases Chemical class 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- PYLWMHQQBFSUBP-UHFFFAOYSA-N monofluorobenzene Chemical class FC1=CC=CC=C1 PYLWMHQQBFSUBP-UHFFFAOYSA-N 0.000 claims description 2
- 238000006722 reduction reaction Methods 0.000 claims description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims 1
- 238000006482 condensation reaction Methods 0.000 claims 1
- 238000010511 deprotection reaction Methods 0.000 abstract description 8
- 238000006170 formylation reaction Methods 0.000 abstract description 5
- 230000022244 formylation Effects 0.000 abstract description 2
- 230000006103 sulfonylation Effects 0.000 abstract 1
- 238000005694 sulfonylation reaction Methods 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 75
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 24
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- 239000002904 solvent Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 238000001816 cooling Methods 0.000 description 17
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 17
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 13
- 239000012044 organic layer Substances 0.000 description 13
- 239000012312 sodium hydride Substances 0.000 description 13
- 229910000104 sodium hydride Inorganic materials 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 10
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- ZFKKLKZBDLEYLE-UHFFFAOYSA-N 2-(2-fluorophenyl)-1h-pyrrole Chemical compound FC1=CC=CC=C1C1=CC=CN1 ZFKKLKZBDLEYLE-UHFFFAOYSA-N 0.000 description 8
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- KQIADDMXRMTWHZ-UHFFFAOYSA-N chloro-tri(propan-2-yl)silane Chemical compound CC(C)[Si](Cl)(C(C)C)C(C)C KQIADDMXRMTWHZ-UHFFFAOYSA-N 0.000 description 8
- 239000010410 layer Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 229940057995 liquid paraffin Drugs 0.000 description 8
- OVRKATYHWPCGPZ-UHFFFAOYSA-N 4-methyloxane Chemical compound CC1CCOCC1 OVRKATYHWPCGPZ-UHFFFAOYSA-N 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 238000000926 separation method Methods 0.000 description 7
- 229950003825 vonoprazan Drugs 0.000 description 7
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 6
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 6
- 238000005160 1H NMR spectroscopy Methods 0.000 description 5
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 5
- 150000001335 aliphatic alkanes Chemical class 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- CNXMDTWQWLGCPE-UHFFFAOYSA-N ditert-butyl-(2-phenylphenyl)phosphane Chemical group CC(C)(C)P(C(C)(C)C)C1=CC=CC=C1C1=CC=CC=C1 CNXMDTWQWLGCPE-UHFFFAOYSA-N 0.000 description 5
- 238000001819 mass spectrum Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 239000011592 zinc chloride Substances 0.000 description 5
- 235000005074 zinc chloride Nutrition 0.000 description 5
- TYHUGKGZNOULKD-UHFFFAOYSA-N 1-fluoro-2-iodobenzene Chemical compound FC1=CC=CC=C1I TYHUGKGZNOULKD-UHFFFAOYSA-N 0.000 description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- KUSUUKJGWNAOJI-UHFFFAOYSA-N [2-(2-fluorophenyl)pyrrol-1-yl]-tri(propan-2-yl)silane Chemical compound FC1=C(C=CC=C1)C=1N(C=CC1)[Si](C(C)C)(C(C)C)C(C)C KUSUUKJGWNAOJI-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- QQVDYSUDFZZPSU-UHFFFAOYSA-M chloromethylidene(dimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)=CCl QQVDYSUDFZZPSU-UHFFFAOYSA-M 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 150000002170 ethers Chemical class 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 4
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 4
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- CXNIUSPIQKWYAI-UHFFFAOYSA-N xantphos Chemical compound C=12OC3=C(P(C=4C=CC=CC=4)C=4C=CC=CC=4)C=CC=C3C(C)(C)C2=CC=CC=1P(C=1C=CC=CC=1)C1=CC=CC=C1 CXNIUSPIQKWYAI-UHFFFAOYSA-N 0.000 description 4
- VNDYJBBGRKZCSX-UHFFFAOYSA-L zinc bromide Chemical compound Br[Zn]Br VNDYJBBGRKZCSX-UHFFFAOYSA-L 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 238000005580 one pot reaction Methods 0.000 description 3
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- VFTFKUDGYRBSAL-UHFFFAOYSA-N 15-crown-5 Chemical compound C1COCCOCCOCCOCCO1 VFTFKUDGYRBSAL-UHFFFAOYSA-N 0.000 description 2
- QDNWNJSLWKHNTM-UHFFFAOYSA-N 2-bromo-1-(2-fluorophenyl)ethanone Chemical compound FC1=CC=CC=C1C(=O)CBr QDNWNJSLWKHNTM-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- IXCSYEVJOAWXRH-UHFFFAOYSA-N 5-(2-fluorophenyl)-1-pyridin-3-ylsulfonylpyrrole-3-carbaldehyde Chemical compound FC1=CC=CC=C1C1=CC(C=O)=CN1S(=O)(=O)C1=CC=CN=C1 IXCSYEVJOAWXRH-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 2
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 238000005874 Vilsmeier-Haack formylation reaction Methods 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 150000003983 crown ethers Chemical class 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 2
- CUONGYYJJVDODC-UHFFFAOYSA-N malononitrile Chemical compound N#CCC#N CUONGYYJJVDODC-UHFFFAOYSA-N 0.000 description 2
- ZUVAACFIEPYYOP-UHFFFAOYSA-N methoxycyclopropane Chemical compound COC1CC1 ZUVAACFIEPYYOP-UHFFFAOYSA-N 0.000 description 2
- LCEDQNDDFOCWGG-UHFFFAOYSA-N morpholine-4-carbaldehyde Chemical compound O=CN1CCOCC1 LCEDQNDDFOCWGG-UHFFFAOYSA-N 0.000 description 2
- JIKUXBYRTXDNIY-UHFFFAOYSA-N n-methyl-n-phenylformamide Chemical compound O=CN(C)C1=CC=CC=C1 JIKUXBYRTXDNIY-UHFFFAOYSA-N 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 229940102001 zinc bromide Drugs 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- ORLCYMQZIPSODD-UHFFFAOYSA-N 1-chloro-2-[chloro(2,2,2-trichloroethoxy)phosphoryl]oxybenzene Chemical compound ClC1=CC=CC=C1OP(Cl)(=O)OCC(Cl)(Cl)Cl ORLCYMQZIPSODD-UHFFFAOYSA-N 0.000 description 1
- BPXKZEMBEZGUAH-UHFFFAOYSA-N 2-(chloromethoxy)ethyl-trimethylsilane Chemical compound C[Si](C)(C)CCOCCl BPXKZEMBEZGUAH-UHFFFAOYSA-N 0.000 description 1
- NOUFLZSMHQHSHA-UHFFFAOYSA-N 2-[2-(2-fluorophenyl)-2-oxoethyl]propanedinitrile Chemical compound FC1=CC=CC=C1C(=O)CC(C#N)C#N NOUFLZSMHQHSHA-UHFFFAOYSA-N 0.000 description 1
- XJAINPOVVPZLBI-UHFFFAOYSA-N 2-methylbutan-2-yl carbonochloridate Chemical compound CCC(C)(C)OC(Cl)=O XJAINPOVVPZLBI-UHFFFAOYSA-N 0.000 description 1
- YBDQLHBVNXARAU-UHFFFAOYSA-N 2-methyloxane Chemical compound CC1CCCCO1 YBDQLHBVNXARAU-UHFFFAOYSA-N 0.000 description 1
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- SNNVSEONCOCCRZ-UHFFFAOYSA-N C1CC=CCCC=C1[Ni]C1=CCCC=CCC1 Chemical compound C1CC=CCCC=C1[Ni]C1=CCCC=CCC1 SNNVSEONCOCCRZ-UHFFFAOYSA-N 0.000 description 1
- FLAKGKCBSLMHQU-UHFFFAOYSA-N CC[Mg] Chemical compound CC[Mg] FLAKGKCBSLMHQU-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 241000590002 Helicobacter pylori Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 238000006411 Negishi coupling reaction Methods 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000007013 Reimer-Tiemann formylation reaction Methods 0.000 description 1
- 238000006958 Rieche formylation reaction Methods 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- RYXZOQOZERSHHQ-UHFFFAOYSA-N [2-(2-diphenylphosphanylphenoxy)phenyl]-diphenylphosphane Chemical compound C=1C=CC=C(P(C=2C=CC=CC=2)C=2C=CC=CC=2)C=1OC1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RYXZOQOZERSHHQ-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000005257 alkyl acyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000005251 aryl acyl group Chemical group 0.000 description 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 1
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- VYPKVJUNYSEWKB-UHFFFAOYSA-N benzyl n-diazocarbamate Chemical compound [N-]=[N+]=NC(=O)OCC1=CC=CC=C1 VYPKVJUNYSEWKB-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000006880 cross-coupling reaction Methods 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- IRXSLJNXXZKURP-UHFFFAOYSA-N fluorenylmethyloxycarbonyl chloride Chemical compound C1=CC=C2C(COC(=O)Cl)C3=CC=CC=C3C2=C1 IRXSLJNXXZKURP-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 229940037467 helicobacter pylori Drugs 0.000 description 1
- UBIJTWDKTYCPMQ-UHFFFAOYSA-N hexachlorophosphazene Chemical compound ClP1(Cl)=NP(Cl)(Cl)=NP(Cl)(Cl)=N1 UBIJTWDKTYCPMQ-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- SIAPCJWMELPYOE-UHFFFAOYSA-N lithium hydride Chemical compound [LiH] SIAPCJWMELPYOE-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- UNBDDZDKBWPHAX-UHFFFAOYSA-N n,n-di(propan-2-yl)formamide Chemical compound CC(C)N(C=O)C(C)C UNBDDZDKBWPHAX-UHFFFAOYSA-N 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- UYLRKRLDQUXYKB-UHFFFAOYSA-N nickel;triphenylphosphane Chemical compound [Ni].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 UYLRKRLDQUXYKB-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical class [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- UJJDEOLXODWCGK-UHFFFAOYSA-N tert-butyl carbonochloridate Chemical compound CC(C)(C)OC(Cl)=O UJJDEOLXODWCGK-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ISHLCKAQWKBMAU-UHFFFAOYSA-N tert-butyl n-diazocarbamate Chemical compound CC(C)(C)OC(=O)N=[N+]=[N-] ISHLCKAQWKBMAU-UHFFFAOYSA-N 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 125000005951 trifluoromethanesulfonyloxy group Chemical group 0.000 description 1
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 1
- COIOYMYWGDAQPM-UHFFFAOYSA-N tris(2-methylphenyl)phosphane Chemical compound CC1=CC=CC=C1P(C=1C(=CC=CC=1)C)C1=CC=CC=C1C COIOYMYWGDAQPM-UHFFFAOYSA-N 0.000 description 1
- 125000002221 trityl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C([*])(C1=C(C(=C(C(=C1[H])[H])[H])[H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/333—Radicals substituted by oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B51/00—Introduction of protecting groups or activating groups, not provided for in the preceding groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Catalysts (AREA)
Abstract
Description
技术领域technical field
本发明涉及作为酸分泌抑制剂的1-[5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-基]-N-甲基甲胺单富马酸盐和其中间体的制造方法。The present invention relates to 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine monohydrate as an acid secretion inhibitor Methods for the manufacture of fumarate salts and intermediates thereof.
背景技术Background technique
下述式所示的1-[5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-基]-N-甲基甲胺单富马酸盐(以下记为富马酸沃诺拉赞)是钾离子竞争性酸阻滞剂,抑制钾离子与H+,K±ATPase的结合,抑制胃酸分泌,因此,被用于胃/十二指肠溃疡等的治疗和预防、幽门螺杆菌除菌时的胃内pH调节。已知富马酸沃诺拉赞与现有的质子泵抑制剂相比,对酸稳定,到达有效浓度迅速,从服用到作用显现为止迅速,且长时间强烈抑制胃酸。1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethylamine monofumaric acid represented by the following formula Salt (hereinafter referred to as vonoprazan fumarate) is a potassium ion-competitive acid blocker, which inhibits the combination of potassium ions with H+, K±ATPase, and inhibits gastric acid secretion. Therefore, it is used in the stomach/duodenum Treatment and prevention of ulcers, etc., and pH adjustment in the stomach during sterilization of Helicobacter pylori. It is known that vonoprazan fumarate is more stable to acid than the existing proton pump inhibitors, reaches an effective concentration quickly, takes it quickly until the effect appears, and strongly inhibits gastric acid for a long time.
关于富马酸沃诺拉赞的制造方法,例如在专利文献1中公开了由下述式所示的氰基化合物经由吡咯体合成作为合成中间体的吡咯-3-甲醛衍生物的方法。Regarding the production method of vonoprazan fumarate, for example, Patent Document 1 discloses a method for synthesizing a pyrrole-3-carbaldehyde derivative as a synthesis intermediate from a cyano compound represented by the following formula via a pyrrole body.
在该方法中,以[2-(2-氟苯基)-2-氧代乙基]丙二腈(a)为原料。记载了该原料可以通过专利文献2记载的方法而制造,公开了通过由α-溴代邻氟苯乙酮与丙二腈的反应来合成。另外,记载了α-溴代邻氟苯乙酮可以通过一般公知的方法来制造。虽然没有具体的记载,但已知有例如在乙酸中与溴反应的方法(非专利文献1),在氯化铝的存在下与溴反应的方法(非专利文献2)。原料的合成由于需要2个工序,因此,目标化合物的制造需要多个工序。另外,在这些反应中,由于用到担心毒性和对环境的影响的丙二睛以及腐蚀性、刺激性强的溴,因此,期望一种进一步考虑到对人体和环境安全的制造方法。另外,5-(2-氟苯基)-1H-吡咯-3-甲醛由原料以收率53%~60%而合成,也期望收率的改善。In this method, [2-(2-fluorophenyl)-2-oxoethyl]malononitrile (a) is used as a raw material. It is described that this raw material can be produced by the method described in Patent Document 2, and it is disclosed that it is synthesized by the reaction of α-bromo-o-fluoroacetophenone and malononitrile. In addition, it is described that α-bromo-o-fluoroacetophenone can be produced by a generally known method. Although not specifically described, for example, a method of reacting with bromine in acetic acid (Non-Patent Document 1) and a method of reacting with bromine in the presence of aluminum chloride (Non-Patent Document 2) are known. Since the synthesis of the raw material requires two steps, the production of the target compound requires a plurality of steps. In addition, in these reactions, since malononitrile, which is concerned about toxicity and environmental impact, and bromine, which is corrosive and irritating, are used, a production method that further considers safety to human body and the environment is desired. In addition, 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde was synthesized from the raw materials in a yield of 53% to 60%, and the improvement of the yield was also desired.
因此,期望一种对人体和环境的影响少、更短工序且收率良好的制造方法。Therefore, a production method with less impact on the human body and the environment, shorter steps, and good yield is desired.
现有技术文献prior art literature
专利文献Patent Literature
专利文献1:日本专利第5819494号公报Patent Document 1: Japanese Patent No. 5819494
专利文献2:日本专利第3140818号公报Patent Document 2: Japanese Patent No. 3140818
非专利文献Non-patent literature
非专利文献1:Organic Synthesis,Coll,Vol.1,127(1941)Non-Patent Document 1: Organic Synthesis, Coll, Vol. 1, 127 (1941)
非专利文献2:Organic Synthesis,Coll,Vol.2,480(1943)Non-Patent Document 2: Organic Synthesis, Coll, Vol. 2, 480 (1943)
非专利文献3:Synthesis,49(16),3692-3699;2017Non-patent document 3: Synthesis, 49(16), 3692-3699; 2017
非专利文献4:Journal of Organic Chemistry,75(9),3109-3112;2010Non-patent document 4: Journal of Organic Chemistry, 75(9), 3109-3112; 2010
发明内容SUMMARY OF THE INVENTION
本发明的目的在于提供在富马酸沃诺拉赞的制造中合成中间体吡咯-3-甲醛衍生物的制造法以及使用了该衍生物的新型的富马酸沃诺拉赞的工业制造法。An object of the present invention is to provide a method for synthesizing an intermediate pyrrole-3-carbaldehyde derivative in the production of vonoprazan fumarate, and an industrial method for producing a novel vonoprazan fumarate using the derivative .
本发明人等进行了深入研究,结果发现通过使用基于容易获得的氟碘苯与吡咯的偶联反应和基于吡咯环上氮原子的适当保护的位置选择性甲酰化反应从而高效率且简便地制造吡咯-3-甲醛衍生物的方法,以至完成了本发明。The inventors of the present invention have conducted intensive studies and, as a result, found that it is possible to efficiently and simply use a regioselective formylation reaction based on a coupling reaction of readily available fluoroiodobenzene and pyrrole and a regioselective formylation reaction based on appropriate protection of nitrogen atoms on the pyrrole ring. A method for producing a pyrrole-3-carbaldehyde derivative has led to the completion of the present invention.
即,which is,
[1]本发明涉及一种5-(2-氟苯基)-1H-吡咯-3-甲醛的制造方法,[1] The present invention relates to a method for producing 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde,
在下述通式(I)所示的吡咯衍生物中向吡咯环的氮原子导入保护基,得到下述式(II)(式中,P表示保护基团)所示的N保护吡咯衍生物,进一步通过甲酰化得到下述式(III)所示的吡咯-3-甲醛衍生物,进一步通过脱保护反应得到下述式(IV)所示的5-(2-氟苯基)-1H-吡咯-3-甲醛。In the pyrrole derivative represented by the following general formula (I), a protecting group is introduced into the nitrogen atom of the pyrrole ring to obtain an N-protected pyrrole derivative represented by the following formula (II) (wherein P represents a protecting group), A pyrrole-3-carbaldehyde derivative represented by the following formula (III) was further obtained by formylation, and 5-(2-fluorophenyl)-1H- represented by the following formula (IV) was further obtained by a deprotection reaction. Pyrrole-3-carbaldehyde.
[2]另外,本发明涉及上述[1]所述的制造方法,其中,所述P所示的保护基为甲硅烷基系保护基。[2] Further, the present invention relates to the production method according to the above [1], wherein the protective group represented by the P is a silyl-based protective group.
[3]另外,本发明涉及上述[1]或[2]所述的制造方法,其中,所述P所示的保护基为三异丙基甲硅烷基。[3] Further, the present invention relates to the production method according to the above [1] or [2], wherein the protecting group represented by the P is a triisopropylsilyl group.
[4]另外,本发明涉及一种上述[1]~[3]所述的化合物(I)的制造方法,所述通式(I)的吡咯衍生物是通过使下述式(V)(式中,L表示离去基团)所示的邻氟苯衍生物在金属催化剂存在下与吡咯反应而得到的。[4] Further, the present invention relates to a method for producing the compound (I) according to the above [1] to [3], wherein the pyrrole derivative of the general formula (I) is obtained by applying the following formula (V)( In the formula, the o-fluorobenzene derivative represented by L represents a leaving group) is obtained by reacting with pyrrole in the presence of a metal catalyst.
[5]另外,本发明涉及上述[4]所述的制造方法,其中,所述金属催化剂为钯催化剂。[5] Further, the present invention relates to the production method according to the above [4], wherein the metal catalyst is a palladium catalyst.
[6]另外,本发明涉及一种1-[5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-基]-N-甲基甲胺的制造方法,将通过所述制造方法得到的通式(IV)所示的5-(2-氟苯基)-1H-吡咯-3-甲醛在无机碱或有机碱的存在下与吡啶-3-磺酰氯或其盐反应而得到下述式(VI)所示的吡咯衍生物,进一步与甲胺缩合后,通过还原反应而得到下述式(VII)所示的1-[5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-基]-N-甲基甲胺。[6] In addition, the present invention relates to 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine The production method of the invention comprises combining the 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde represented by the general formula (IV) obtained by the production method with pyridine-3 in the presence of an inorganic base or an organic base - Sulfonyl chloride or its salt is reacted to obtain a pyrrole derivative represented by the following formula (VI), and further condensed with methylamine, and then 1-[5-(2 represented by the following formula (VII) is obtained by a reduction reaction -Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine.
[7]另外,本发明涉及一种1-[5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-基]-N-甲基甲胺单富马酸盐的制造方法,利用了通过所述制造方法得到的通式(VII)的化合物和富马酸。[7] In addition, the present invention relates to 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine The production method of monofumarate utilizes the compound of general formula (VII) obtained by the above production method and fumaric acid.
本发明能够使用吡咯、2-氟碘苯等容易获得的原料廉价且以短时间且短工序并以良好的收率(70%以上)得到5-(2-氟苯基)-1H-吡咯-3-甲醛,与现有方法相比,经济性和生产率高,适于工业生产。进而,关于过渡金属催化剂的使用,也抑制为极少量,且在上游工序中使用,由此能够进一步减少在最终产物中残留金属杂质的担心。In the present invention, 5-(2-fluorophenyl)-1H-pyrrole can be obtained in a short time and in a short process and in a good yield (70% or more) using readily available raw materials such as pyrrole and 2-fluoroiodobenzene at low cost. 3-formaldehyde, compared with the existing methods, has high economy and productivity, and is suitable for industrial production. Furthermore, the use of the transition metal catalyst is also suppressed to an extremely small amount, and the use of the transition metal catalyst in the upstream process can further reduce the fear of remaining metal impurities in the final product.
具体实施方式Detailed ways
以下,对本发明进一步详细地进行说明。Hereinafter, the present invention will be described in further detail.
上述通式(V)中,作为L所示的离去基团,可举出氯、溴、碘这样的卤素原子、甲磺酰氧基、三氟甲磺酰氧基这样的低级烷烃磺酰氧基、苯磺酰氧基、对甲苯磺酰氧基这样的芳基磺酰氧基等。In the above-mentioned general formula (V), examples of the leaving group represented by L include halogen atoms such as chlorine, bromine and iodine, and lower alkanesulfonyl such as methanesulfonyloxy and trifluoromethanesulfonyloxy. An arylsulfonyloxy group such as an oxy group, a benzenesulfonyloxy group, a p-toluenesulfonyloxy group, and the like.
上述通式(II)和(III)中,作为P所示的吡咯环氮保护基,可举出甲硅烷基系保护基或者烷基系保护基、杂芳基系保护基、酰基系保护基、氨基甲酸酯系保护基等,作为甲硅烷基系保护基,可举出三甲基甲硅烷基、三乙基甲硅烷基、叔丁基二甲基甲硅烷基、三异丙基甲硅烷基、叔丁基二苯基甲硅烷基等,优选为叔丁基二甲基甲硅烷基、三异丙基甲硅烷基等。In the above-mentioned general formulae (II) and (III), the pyrrole ring nitrogen protecting group represented by P includes a silyl-based protecting group, an alkyl-based protecting group, a heteroaryl-based protecting group, and an acyl-based protecting group. , urethane-based protecting groups, etc. Examples of silyl-based protecting groups include trimethylsilyl, triethylsilyl, tert-butyldimethylsilyl, triisopropylmethyl A silyl group, a tert-butyldiphenylsilyl group, and the like are preferably a tert-butyldimethylsilyl group, a triisopropylsilyl group, and the like.
作为烷基系保护基,可举出烯丙基、二甲氧基甲基、二乙氧基甲基、叔丁基、三苯基甲基、苄基、4-甲氧基苄基等。Examples of the alkyl-based protecting group include allyl, dimethoxymethyl, diethoxymethyl, t-butyl, triphenylmethyl, benzyl, 4-methoxybenzyl and the like.
作为杂芳基系保护基,可举出2-吡啶基、4-吡啶基、2-吡嗪基、2-嘧啶基、2-三嗪基。Examples of the heteroaryl-based protecting group include a 2-pyridyl group, a 4-pyridyl group, a 2-pyrazinyl group, a 2-pyrimidinyl group, and a 2-triazinyl group.
作为氨基甲酸酯系保护基,可举出甲氧基羰基、乙氧基羰基、叔丁氧基羰基、叔戊氧基羰基、2,2,2-三氯乙氧基羰基、苄氧基羰基、对氯苄氧基羰基、对甲氧基苄氧基羰基、对硝基苄氧基羰基、对苯基偶氮苄氧基羰基、对甲氧基苯基偶氮苄氧基羰基、3,5-二甲氧基苄氧基羰基、3,4,5-三甲氧基苄氧基羰基、对联苯异丙氧基羰基、二异丙基甲氧基羰基、2-(三甲基甲硅烷基)乙氧基羰基、9-芴基甲氧基羰基等。Examples of carbamate-based protecting groups include methoxycarbonyl, ethoxycarbonyl, tert-butoxycarbonyl, tert-amyloxycarbonyl, 2,2,2-trichloroethoxycarbonyl, and benzyloxy Carbonyl, p-chlorobenzyloxycarbonyl, p-methoxybenzyloxycarbonyl, p-nitrobenzyloxycarbonyl, p-phenylazobenzyloxycarbonyl, p-methoxyphenylazobenzyloxycarbonyl, 3 ,5-dimethoxybenzyloxycarbonyl, 3,4,5-trimethoxybenzyloxycarbonyl, p-biphenylisopropoxycarbonyl, diisopropylmethoxycarbonyl, 2-(trimethylmethyl) Silyl) ethoxycarbonyl, 9-fluorenylmethoxycarbonyl and the like.
另外,作为其它保护基,可以使用甲磺酰基等烷基磺酰基、对甲苯磺酰基等芳基磺酰基、乙酰基等烷基酰基、苯甲酰基等芳基酰基。In addition, as other protective groups, alkylsulfonyl groups such as methanesulfonyl groups, arylsulfonyl groups such as p-toluenesulfonyl groups, alkyl acyl groups such as acetyl groups, and aryl acyl groups such as benzoyl groups can be used.
这些保护基中,作为保护基,从收率等方面考虑,优选甲硅烷基系保护基,特别优选为三甲基甲硅烷基、三乙基甲硅烷基、叔丁基二甲基甲硅烷基、三异丙基甲硅烷基,进一步优选为三异丙基甲硅烷基。Among these protecting groups, from the viewpoint of yield and the like, silyl-based protecting groups are preferable, and trimethylsilyl, triethylsilyl, and tert-butyldimethylsilyl are particularly preferable as protecting groups. , a triisopropylsilyl group, more preferably a triisopropylsilyl group.
在本发明中,作为在由化合物(V)得到化合物(I)的反应中使用的金属催化剂,可以使用镍催化剂、钯催化剂等。In the present invention, as the metal catalyst used in the reaction of obtaining the compound (I) from the compound (V), a nickel catalyst, a palladium catalyst, or the like can be used.
作为本发明中使用的镍催化剂,可举出双(1,5-环辛二烯基)镍等0价的镍催化剂、氯化镍、双(三苯基膦)氯化镍等2价的镍催化剂等,根据需要可以加入三苯基膦、2-(二叔丁基膦基)联苯、Xantphos、双[2-(二苯基膦基)苯基]醚(以下为DPEPhos)、(±)-2,2’-双(二苯基膦基)-1,1’-联萘(以下为(±)-BINAP)等膦配体、N,N,N’,N’-四甲基乙二胺等。Examples of the nickel catalyst used in the present invention include 0-valent nickel catalysts such as bis(1,5-cyclooctadienyl)nickel, and divalent nickel catalysts such as nickel chloride and bis(triphenylphosphine)nickel chloride. Nickel catalyst, etc., if necessary, triphenylphosphine, 2-(di-tert-butylphosphino)biphenyl, Xantphos, bis[2-(diphenylphosphino)phenyl]ether (hereinafter DPEPhos), ( Phosphine ligands such as ±)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl (hereinafter (±)-BINAP), N,N,N',N'-tetramethyl Ethylenediamine, etc.
作为本发明中使用的钯催化剂,可举出钯碳、四(三苯基膦)钯等0价的钯催化剂或氯化钯、乙酸钯、(二氯双(三邻甲苯基膦))钯等2价的钯催化剂,根据需要可以加入三苯基膦、2-(二叔丁基膦基)联苯、Xantphos、DPEPhos、(±)-BINAP等膦配体等。Examples of the palladium catalyst used in the present invention include 0-valent palladium catalysts such as palladium carbon and tetrakis(triphenylphosphine)palladium, palladium chloride, palladium acetate, and (dichlorobis(tri-o-tolylphosphine))palladium. Divalent palladium catalysts such as triphenylphosphine, phosphine ligands such as 2-(di-tert-butylphosphino)biphenyl, Xantphos, DPEPhos, (±)-BINAP, etc. can be added as needed.
作为本发明中使用的碱,可以加入三乙基胺、二异丙基乙基胺等叔胺、氢化锂、氢化钠、氢化钾、氨基钠、二异丙基氨基锂(以下为LDA)、六甲基二硅基氨基锂(以下为LiHMDS)、乙基镁、碳酸钠、碳酸钙等金属碱等。As the base used in the present invention, tertiary amines such as triethylamine and diisopropylethylamine, lithium hydride, sodium hydride, potassium hydride, sodium amide, lithium diisopropylamide (hereinafter referred to as LDA), Metal bases such as lithium hexamethyldisilazide (hereinafter, LiHMDS), ethylmagnesium, sodium carbonate, calcium carbonate, and the like.
将本发明的富马酸沃诺拉赞的制造中的合成中间体吡咯-3-甲醛衍生物的制造法和使用了该衍生物的富马酸沃诺拉赞的制造方法示于以下。The production method of a synthetic intermediate pyrrole-3-carbaldehyde derivative in the production of vonoprazan fumarate of the present invention, and the production method of vonoprazan fumarate using the derivative are shown below.
(化合物(I)的制造)(Production of Compound (I))
化合物(I)可以通过非专利文献3、非专利文献4中记载的交叉偶联反应等来制造。例如,可以通过使用根岸偶联反应而使用未被卤化的未取代的吡咯,在氮或氩等非活性气体气氛下向1~3当量的上述碱、优选为金属碱、更优选为氢化钠的二乙基醚、环丙基甲基醚、四氢呋喃、4-甲基四氢吡喃、二烷、单甘醇二甲醚、二甘醇二甲醚等醚类、苯、甲苯、二甲苯等芳香族烃类等的溶剂悬浮液中在-10℃~室温下滴加1~3当量的吡咯/上述溶剂的溶液并搅拌10分钟~1小时后,加入1~3当量的卤化锌(氯化锌、溴化锌)等无机锌、二新戊酰基锌等有机锌(优选为卤化锌、特别优选为氯化锌)并在室温下搅拌10分钟~1小时。接着,加入1~3当量的化合物(V)、0.0001~1.0当量(优选为0.001~0.003当量)的钯等上述催化剂以及0.0001~1.0当量(优选为0.001~0.003当量)的上述膦配体,并在室温~150℃(优选为90~130℃)下反应5分钟~24小时,由此可以制造化合物(I)。Compound (I) can be produced by the cross-coupling reaction described in Non-Patent Document 3 and Non-Patent Document 4, or the like. For example, by using a Negishi coupling reaction using unhalogenated unsubstituted pyrrole, under an inert gas atmosphere such as nitrogen or argon, 1 to 3 equivalents of the above-mentioned base, preferably a metal base, more preferably sodium hydride can be added to Diethyl ether, cyclopropyl methyl ether, tetrahydrofuran, 4-methyltetrahydropyran, diethyl ether To the solvent suspension of ethers such as alkane, monoglyme and diglyme, aromatic hydrocarbons such as benzene, toluene and xylene, etc., dropwise add 1 to 3 equivalents of After stirring the pyrrole/solvent solution for 10 minutes to 1 hour, 1 to 3 equivalents of inorganic zinc such as zinc halide (zinc chloride, zinc bromide) and organic zinc such as dipivaloyl zinc (preferably zinc halide, zinc bromide, etc.) are added. Particularly preferred is zinc chloride) and stirred at room temperature for 10 minutes to 1 hour. Next, 1 to 3 equivalents of the compound (V), 0.0001 to 1.0 equivalents (preferably 0.001 to 0.003 equivalents) of the above-mentioned catalysts such as palladium, and 0.0001 to 1.0 equivalents (preferably 0.001 to 0.003 equivalents) of the above-mentioned phosphine ligands are added, and Compound (I) can be produced by reacting at room temperature to 150°C (preferably 90 to 130°C) for 5 minutes to 24 hours.
(化合物(II)的制造)(Production of Compound (II))
化合物(II)可以通过向化合物(I)导入保护基来制造,保护基的导入根据选择的保护基而制造方法不同,但可以采用一般公知的方法。例如在导入甲硅烷基系的保护基时,向1~1.5当量的上述碱、优选为金属碱、更优选为氢化钠的二乙基醚、环丙基甲基醚、四氢呋喃、4-甲基四氢吡喃、二烷、单甘醇二甲醚、二甘醇二甲醚等醚类或N,N-二甲基甲酰胺等非质子性极性溶剂或者它们的混合溶剂、优选为醚类等的溶剂悬浮液中在-10℃~室温下滴加化合物(I)后,加入冠醚、四乙二胺、二甲基咪唑啉酮等金属螯合剂、优选为二甲基咪唑啉酮,接着滴加1~1.5当量的保护基导入试剂使其反应5分钟~3小时,由此可以制造化合物(II)。The compound (II) can be produced by introducing a protecting group into the compound (I). The production method for introducing the protecting group varies depending on the protecting group selected, but a generally known method can be employed. For example, when introducing a silyl-based protecting group, 1 to 1.5 equivalents of the above-mentioned base, preferably a metal base, more preferably diethyl ether of sodium hydride, cyclopropyl methyl ether, tetrahydrofuran, 4-methyl Tetrahydropyran, Di Ethers such as alkane, monoglyme, diglyme, etc., or aprotic polar solvents such as N,N-dimethylformamide, or a mixed solvent thereof, preferably a solvent suspension of ethers, etc. After the compound (I) is added dropwise at -10°C to room temperature, a metal chelating agent such as crown ether, tetraethylenediamine, and dimethylimidazolidinone, preferably dimethylimidazolidinone, is added, followed by dropwise addition of 1 to Compound (II) can be produced by reacting 1.5 equivalents of the protecting group-introducing reagent for 5 minutes to 3 hours.
另外,导入氨基甲酸酯系保护基时,根据氨基甲酸酯系保护基的种类而反应条件不同,例如对化合物(I)导入叔丁氧基羰基(Boc基)、叔戊氧基羰基(Aoc基)或苄氧基羰基(Z基)、9-芴基甲氧基羰基(Fmoc)基、2,2,2-三氯乙氧基羰基、2-(三甲基甲硅烷基)乙氧基羰基等时,可以通过在二烷、二烷/水、二氯甲烷、四氢呋喃等溶剂中,在三乙基胺、吡啶等有机碱、氢化钠、氢氧化钾、氢氧化钠、碳酸氢钾、碳酸氢钠等无机碱的存在下,使二碳酸二叔丁酯((Boc)2O)、叔丁氧基羰基氯化物、苄氧基羰基氯化物、叔戊氧基羰基氯化物、9-芴基甲氧基羰基氯化物、氯甲酸2,2,2-三氯乙酯、2-(三甲基甲硅烷基)乙氧基甲基氯化物、叔丁氧基羰基叠氮化物、苄氧基羰基叠氮化物等一般公知的Boc基等的导入试剂1~1.5当量在0℃~100℃反应5分钟~10小时而制造。In addition, when introducing a carbamate-based protecting group, the reaction conditions differ depending on the type of carbamate-based protecting group. For example, a tert-butoxycarbonyl group (Boc group), a tert-amyloxycarbonyl group ( Aoc group) or benzyloxycarbonyl (Z group), 9-fluorenylmethoxycarbonyl (Fmoc) group, 2,2,2-trichloroethoxycarbonyl, 2-(trimethylsilyl)ethyl Oxycarbonyl, etc., can be alkane, two In solvents such as alkane/water, dichloromethane, tetrahydrofuran, etc., in the presence of organic bases such as triethylamine and pyridine, and inorganic bases such as sodium hydride, potassium hydroxide, sodium hydroxide, potassium bicarbonate, and sodium bicarbonate, the Di-tert-butyl dicarbonate ((Boc) 2 O), tert-butoxycarbonyl chloride, benzyloxycarbonyl chloride, tert-amyloxycarbonyl chloride, 9-fluorenylmethoxycarbonyl chloride, chloroformic acid Commonly known Boc such as 2,2,2-trichloroethyl ester, 2-(trimethylsilyl)ethoxymethyl chloride, tert-butoxycarbonyl azide, benzyloxycarbonyl azide, etc. 1 to 1.5 equivalents of introducing reagents such as radicals are produced by reacting at 0°C to 100°C for 5 minutes to 10 hours.
(化合物(III)的制造)(Production of Compound (III))
化合物(III)可以通过一般公知的甲酰化反应、例如Vilsmeier反应、Rieche反应、Daff反应、Reimer-Tiemann反应等来制造,例如在Vilsmeier反应中,由N,N-二甲基甲酰胺(DMF)、N-甲基甲酰苯胺(MFA)、N-甲酰基吗啉、N,N-二异丙基甲酰胺等N,N-二取代甲酰胺和三氯氧磷、草酰氯、亚硫酰氯、三苯基膦-溴、六氯环三磷腈等酰氯制备Vilsmeier试剂((氯亚甲基)二甲基氯化铵)或者购入市售品,将其和化合物(II)在溶剂例如三氯氧磷;或二氯甲烷、二氯乙烷、氯仿、四氯化碳、氯苯等卤代烃类;苯、甲苯、硝基苯等芳香族烃类;四氢呋喃、甲基四氢吡喃、二烷等醚类或乙酸乙酯、乙腈、N,N-二甲基甲酰胺等非质子性极性溶剂或者它们的混合溶剂、优选为醚系溶剂、芳香族烃类、非质子性极性溶剂或者它们的混合溶剂、更优选为甲基四氢吡喃中,在0~100℃(优选为40~80℃)搅拌0.5~12小时后使其反应,由此可以制造化合物(III)。Compound (III) can be produced by generally known formylation reactions, such as Vilsmeier reaction, Rieche reaction, Daff reaction, Reimer-Tiemann reaction, etc., for example, in Vilsmeier reaction, from N,N-dimethylformamide (DMF) ), N-methylformanilide (MFA), N-formylmorpholine, N,N-diisopropylformamide and other N,N-disubstituted formamides and phosphorus oxychloride, oxalyl chloride, sulfite Acid chlorides, triphenylphosphine-bromide, hexachlorocyclotriphosphazene and other acid chlorides were prepared with Vilsmeier reagent ((chloromethylene)dimethylammonium chloride) or purchased commercially, and mixed with compound (II) in a solvent For example, phosphorus oxychloride; or halogenated hydrocarbons such as dichloromethane, dichloroethane, chloroform, carbon tetrachloride, and chlorobenzene; aromatic hydrocarbons such as benzene, toluene, and nitrobenzene; tetrahydrofuran, methyltetrahydrofuran, etc. Pyran, Di Ethers such as alkane, aprotic polar solvents such as ethyl acetate, acetonitrile, N,N-dimethylformamide, or their mixed solvents, preferably ether-based solvents, aromatic hydrocarbons, and aprotic polar solvents Alternatively, compound (III) can be produced by stirring in a mixed solvent of these, more preferably methyltetrahydropyran, at 0 to 100°C (preferably 40 to 80°C) for 0.5 to 12 hours and then reacting.
(化合物(IV)的制造)(Production of Compound (IV))
化合物(IV)可以由化合物(III)的脱保护反应来制造。脱保护反应根据保护基而不同,可以使用一般公知的方法,例如,保护基为甲硅烷基系保护基时,可以通过在四氢呋喃等溶液中在-10℃~室温下使四丁基氟化铵、HF吡啶络合物、HF三乙基胺络合物等氟源反应来制造。另外,即使在盐酸、三氟乙酸等酸性条件下、氢氧化钠水溶液等碱性条件下,也同样地进行甲硅烷基系保护基的脱保护反应,可以制造化合物(IV)。脱保护试剂可以使用相对于化合物(III)为3~10当量(优选为5当量)的氢氧化钠水溶液。Compound (IV) can be produced by deprotection reaction of compound (III). The deprotection reaction varies depending on the protecting group, and generally known methods can be used. For example, when the protecting group is a silyl-based protecting group, tetrabutylammonium fluoride can be obtained by deprotecting tetrabutylammonium fluoride in a solution such as tetrahydrofuran at -10°C to room temperature. , HF pyridine complex, HF triethylamine complex and other fluorine sources react to produce. In addition, even under acidic conditions such as hydrochloric acid and trifluoroacetic acid, and under basic conditions such as sodium hydroxide aqueous solution, the deprotection reaction of the silyl-based protecting group proceeds in the same manner to produce compound (IV). As the deprotection reagent, an aqueous sodium hydroxide solution in an amount of 3 to 10 equivalents (preferably 5 equivalents) can be used with respect to compound (III).
另外,在氨基甲酸酯系的保护基的情况下,根据氨基甲酸酯系保护基的种类而反应条件不同,可以通过一般公知的方法来进行,例如可以通过在氢气氛下,在钯黑、钯碳等的存在下,通过催化还原或者根据保护基适当选择乙酸/溴化氢、三氟乙酸、盐酸/有机溶剂等来进行。In addition, in the case of a carbamate-based protective group, the reaction conditions vary depending on the type of carbamate-based protective group, and the reaction can be carried out by a generally known method, for example, by using palladium black in a hydrogen atmosphere. It is carried out by catalytic reduction in the presence of , palladium on carbon or the like, or by appropriately selecting acetic acid/hydrogen bromide, trifluoroacetic acid, hydrochloric acid/organic solvent, etc. according to the protecting group.
另外,化合物(IV)可以在不从化合物(II)分离化合物(III)的情况下通过一锅操作来制造。此时,可以通过在上述化合物(II)至化合物(III)的反应结束后,在反应体系中加入用于上述脱保护的试剂来进行。In addition, compound (IV) can be produced by a one-pot operation without isolating compound (III) from compound (II). At this time, it can be performed by adding the reagent for the above-mentioned deprotection to the reaction system after the completion of the reaction of the above-mentioned compound (II) to the compound (III).
另外,化合物(IV)也可以在不从化合物(I)分离化合物(II)、化合物(III)的情况下通过一锅操作来制造,例如在上述化合物(III)的制造中的反应结束后,在该反应体系中加入上述化合物(IV)的制造中的反应试剂,反应结束后,进一步在反应体系中加入用于上述脱保护反应的试剂,同样地进行反应,由此可以制造化合物(IV)。任一制造中的试剂的量关系可以使用与上述同样的量。In addition, compound (IV) can also be produced by one-pot operation without separating compound (II) and compound (III) from compound (I). For example, after the reaction in the production of compound (III) is completed, Compound (IV) can be produced by adding the reagent used in the production of the above-mentioned compound (IV) to the reaction system, and after the completion of the reaction, adding the reagent for the above-mentioned deprotection reaction to the reaction system and performing the reaction in the same manner. . The quantitative relationship of the reagents in any production can be used in the same amounts as those described above.
(化合物(VI)的制造)(Production of Compound (VI))
在-10℃~室温下向1~1.5当量的氢化钠/四氢呋喃的悬浮液滴加加入化合物(IV)的四氢呋喃等的溶液,搅拌0.5~1小时后,进一步在冠醚、四甲基乙二胺、二甲基咪唑啉酮等金属螯合剂的存在下在-10℃~室温下搅拌0.5~1小时,接下来加入吡啶-3-磺酰氯,在0℃搅拌0.5小时。进一步加入吡啶-3-磺酰氯,在-10℃~室温下搅拌0.5~1小时,由此可以制造化合物(VI)。A solution of compound (IV) in tetrahydrofuran, etc. was added dropwise to a suspension of 1 to 1.5 equivalents of sodium hydride/tetrahydrofuran at -10°C to room temperature, and after stirring for 0.5 to 1 hour, the solution was further added to crown ether, tetramethylethylenedi The mixture was stirred at -10°C to room temperature for 0.5 to 1 hour in the presence of a metal chelating agent such as an amine and dimethylimidazolidinone, and then pyridine-3-sulfonyl chloride was added, followed by stirring at 0°C for 0.5 hour. Further, pyridine-3-sulfonyl chloride is added, and the compound (VI) can be produced by stirring at -10°C to room temperature for 0.5 to 1 hour.
另外,化合物(VI)可以通过在化合物(IV)的二氯甲烷、乙腈等溶液中,在0℃~室温下添加三乙基胺、N,N-二异丙基胺等碱、催化剂量的4-二甲基氨基吡啶、吡啶-3-磺酰氯并在室温~100℃搅拌0.5~12小时来制造。In addition, compound (VI) can be obtained by adding a base such as triethylamine, N,N-diisopropylamine, or the like, or a catalyst in a catalytic amount to a solution of compound (IV) in dichloromethane, acetonitrile, or the like at 0°C to room temperature. 4-dimethylaminopyridine and pyridine-3-sulfonyl chloride are produced by stirring at room temperature to 100° C. for 0.5 to 12 hours.
(化合物(VII)的制造)(Production of Compound (VII))
在0℃~室温下向化合物(VI)的甲醇等的溶液中滴加加入甲胺的甲醇等的溶液,搅拌0.5~1小时,在0℃~室温下加入1~3当量的硼氢化钠等还原剂使其反应0.5~1小时,由此可以得到化合物(VII)。A solution of methylamine in methanol, etc. is added dropwise to a solution of compound (VI) in methanol etc. at 0°C to room temperature, stirred for 0.5 to 1 hour, and 1 to 3 equivalents of sodium borohydride etc. are added at 0°C to room temperature Compound (VII) can be obtained by reacting the reducing agent for 0.5 to 1 hour.
(富马酸沃诺拉赞的制造)(Manufacture of Vonorazan Fumarate)
在0℃~室温下向化合物(VII)的乙酸乙酯、甲醇等的溶液中加入富马酸的甲醇等的溶液,搅拌0.5~1小时,滤取析出的晶体,根据需要用甲醇/水进行重结晶,由此可以制造富马酸沃诺拉赞。A solution of fumaric acid in methanol or the like is added to a solution of compound (VII) in ethyl acetate, methanol, or the like at 0°C to room temperature, followed by stirring for 0.5 to 1 hour. By recrystallization, vornorazan fumarate can be produced.
实施例Example
以下,利用实施例、比较例和试验例对本发明更详细地进行说明,但本发明并不限定于这些。Hereinafter, the present invention will be described in more detail using Examples, Comparative Examples, and Test Examples, but the present invention is not limited to these.
实施例1Example 1
2-(2-氟苯基)-1H-吡咯的制造Production of 2-(2-fluorophenyl)-1H-pyrrole
在氢化钠(分散于60%液体石蜡,1.2g,30.0mmol)与四氢呋喃(10mL)的悬浮液中在冰冷下滴加吡咯(2.1mL,30.0mmol)并搅拌0.5小时后,加入氯化锌(4.1g,30.0mmol)并在室温下搅拌0.5小时。接下来,加入乙酸钯(11mg,0.05mmol)、2-(二叔丁基膦基)联苯(15mg,0.05mmol)和1-氟-2-碘苯(1.1mL,10.0mmol)并脱气后,在60℃下搅拌6小时。将反应混合物在0℃冷却的同时滴加水,过滤不溶物后,用乙酸乙酯分液。在水层中加入乙酸乙酯再度萃取后,将有机层合并并用饱和食盐水清洗。在减压下馏去溶剂后,通过硅胶柱色谱进行精制,在减压下进行干燥,由此得到标题化合物(1.18g,收率74%)。Pyrrole (2.1 mL, 30.0 mmol) was added dropwise to a suspension of sodium hydride (dispersed in 60% liquid paraffin, 1.2 g, 30.0 mmol) and tetrahydrofuran (10 mL) under ice-cooling, and after stirring for 0.5 hours, zinc chloride ( 4.1 g, 30.0 mmol) and stirred at room temperature for 0.5 h. Next, palladium acetate (11 mg, 0.05 mmol), 2-(di-tert-butylphosphino)biphenyl (15 mg, 0.05 mmol) and 1-fluoro-2-iodobenzene (1.1 mL, 10.0 mmol) were added and degassed Then, it stirred at 60 degreeC for 6 hours. Water was added dropwise to the reaction mixture while cooling at 0°C, and the insoluble matter was filtered, followed by liquid separation with ethyl acetate. After adding ethyl acetate to the aqueous layer and extracting again, the organic layers were combined and washed with saturated brine. After the solvent was distilled off under reduced pressure, it was purified by silica gel column chromatography and dried under reduced pressure to obtain the title compound (1.18 g, yield 74%).
质谱(ESI):m/z calcd for C10H7FN[M-H]-:160.06;found:160.18;1H-NMR(400MHz,CDCl3)δ(ppm):6.30-6.33(m,1H),6.64-6.67(m,1H),6.90-6.93(m,1H),7.07-7.16(m,1H),7.13-7.17(m,2H),7.60-7.65(m,1H),9.05(brs,1H).Mass spectrum (ESI): m/z calcd for C10H7FN[M-H]-: 160.06; found: 160.18; 1H-NMR (400MHz, CDCl3) δ (ppm): 6.30-6.33 (m, 1H), 6.64-6.67 ( m, 1H), 6.90-6.93 (m, 1H), 7.07-7.16 (m, 1H), 7.13-7.17 (m, 2H), 7.60-7.65 (m, 1H), 9.05 (brs, 1H).
实施例2Example 2
2-(2-氟苯基)-1-(三异丙基甲硅烷基)-1H-吡咯的制造Production of 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole
在氢化钠(分散于60%液体石蜡,64mg,1.61mmol)与四氢呋喃(2mL)的悬浮液中在冰冷下滴加2-(2-氟苯基)-1H-吡咯(172mg,1.07mmol)的四氢呋喃(2mL)溶液并搅拌0.5小时后,加入15-冠-5-醚(0.32mL,1.61mmol)并在0℃下搅拌0.5小时。接下来滴加三异丙基甲硅烷基氯化物(0.35mL,1.61mmol)并在室温下搅拌4小时。冷却至0℃,滴加水,用乙酸乙酯分液。在水层中加入乙酸乙酯再次萃取后,将有机层合并并用饱和食盐水清洗。在减压下馏去溶剂后,用硅胶柱进行精制并在减压下干燥,由此得到标题化合物(272mg,收率80%)。To a suspension of sodium hydride (dispersed in 60% liquid paraffin, 64 mg, 1.61 mmol) and tetrahydrofuran (2 mL) was added dropwise a solution of 2-(2-fluorophenyl)-1H-pyrrole (172 mg, 1.07 mmol) under ice-cooling. After a solution of tetrahydrofuran (2 mL) and stirring for 0.5 h, 15-crown-5-ether (0.32 mL, 1.61 mmol) was added and stirred at 0°C for 0.5 h. Next, triisopropylsilyl chloride (0.35 mL, 1.61 mmol) was added dropwise and stirred at room temperature for 4 hours. It was cooled to 0 degreeC, water was added dropwise, and the liquid was separated with ethyl acetate. After adding ethyl acetate to the aqueous layer and extracting again, the organic layers were combined and washed with saturated brine. After the solvent was distilled off under reduced pressure, it was purified with a silica gel column and dried under reduced pressure to obtain the title compound (272 mg, yield 80%).
质谱(ESI):m/z calcd for C19H28FNNaSi[M+Na]+:340.19;found:340.16;1H-NMR(400MHz,CDCl3)δ(ppm):1.01(d,J=6.9Hz,18H),1.13-1.21(m,3H),6.25(dd,J=3.2,1.2Hz,1H),6.37(t,J=3.2Hz,1H),6.93(dd,J=2.8,2.0Hz,1H),7.03-7.12(m,2H),7.29-7.37(m,2H).Mass spectrum (ESI): m/z calcd for C19H28FNNaSi[M+Na]+: 340.19; found: 340.16; 1H-NMR (400MHz, CDCl3) δ (ppm): 1.01 (d, J=6.9Hz, 18H), 1.13 -1.21(m, 3H), 6.25(dd, J=3.2, 1.2Hz, 1H), 6.37(t, J=3.2Hz, 1H), 6.93(dd, J=2.8, 2.0Hz, 1H), 7.03- 7.12(m, 2H), 7.29-7.37(m, 2H).
实施例3Example 3
5-(2-氟苯基)-1H-吡咯-3-甲醛的制造Production of 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde
在2-(2-氟苯基)-1-(三异丙基甲硅烷基)-1H-吡咯(100mg,0.32mmol)的二氯甲烷(3.0mL)溶液中在冰冷下加入Vilsmeier试剂(123mg,0.96mmol)并在40℃搅拌0.5小时。在减压下馏去溶剂后,加入氢氧化钠水溶液(1.0M,3mL)并在室温下搅拌6小时,加入乙酸乙酯进行分液。在水层中加入乙酸乙酯再次萃取后,将有机层合并并用饱和食盐水清洗。用硅胶柱进行精制并在减压下干燥,由此得到标题化合物(48mg,收率80%)。To a solution of 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole (100 mg, 0.32 mmol) in dichloromethane (3.0 mL) was added Vilsmeier reagent (123 mg) under ice-cooling , 0.96 mmol) and stirred at 40 °C for 0.5 h. After the solvent was evaporated under reduced pressure, an aqueous sodium hydroxide solution (1.0 M, 3 mL) was added, the mixture was stirred at room temperature for 6 hours, and ethyl acetate was added for liquid separation. After adding ethyl acetate to the aqueous layer and extracting again, the organic layers were combined and washed with saturated brine. Purification with a silica gel column and drying under reduced pressure gave the title compound (48 mg, yield 80%).
质谱(ESI):m/z calcd for C11H8FNNaO[M+Na]+:212.05;found:212.03;1H-NMR(400MHz,CDCl3)δ(ppm):7.07(dd,J=2.0,1.2Hz,1H),7.12-7.26(m,3H),7.53(dd,J=2.8,1.2Hz,1H),7.64(dt,J=7.6,1.6Hz,1H),9.45(brs,1H),9.86(s,1H).Mass spectrum (ESI): m/z calcd for C11H8FNNaO[M+Na]+: 212.05; found: 212.03; 1H-NMR (400MHz, CDCl3) δ (ppm): 7.07 (dd, J=2.0, 1.2Hz, 1H) , 7.12-7.26(m, 3H), 7.53(dd, J=2.8, 1.2Hz, 1H), 7.64(dt, J=7.6, 1.6Hz, 1H), 9.45(brs, 1H), 9.86(s, 1H) ).
实施例4Example 4
5-(2-氟苯基)-1H-吡咯-3-甲醛的制造Production of 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde
在氢化钠(分散于60%液体石蜡,1.2g,30.0mmol)与4-甲基四氢吡喃(10mL)的悬浮液中在冰冷下滴加吡咯(2.1mL,30.0mmol)并搅拌0.5小时后,加入氯化锌(4.1g,30.0mmol)并在室温下搅拌0.5小时。接下来加入乙酸钯(11mg,0.05mmol)、2-(二叔丁基膦基)联苯(15mg,0.05mmol)和1-氟-2-碘苯(1.1mL,10.0mmol),在100℃搅拌0.5小时。将反应混合物在0℃冷却的同时滴加28%氨水,过滤不溶物后,用乙酸乙酯分液。在减压下馏去溶剂后,以粗产物的形式得到2-(2-氟苯基)-1H-吡咯。To a suspension of sodium hydride (dispersed in 60% liquid paraffin, 1.2 g, 30.0 mmol) and 4-methyltetrahydropyran (10 mL) was added dropwise pyrrole (2.1 mL, 30.0 mmol) under ice cooling and stirred for 0.5 hour After that, zinc chloride (4.1 g, 30.0 mmol) was added and stirred at room temperature for 0.5 hours. Next, palladium acetate (11 mg, 0.05 mmol), 2-(di-tert-butylphosphino)biphenyl (15 mg, 0.05 mmol) and 1-fluoro-2-iodobenzene (1.1 mL, 10.0 mmol) were added at 100°C Stir for 0.5 hour. While cooling the reaction mixture at 0°C, 28% aqueous ammonia was added dropwise, and the insoluble matter was filtered, followed by liquid separation with ethyl acetate. After the solvent was distilled off under reduced pressure, 2-(2-fluorophenyl)-1H-pyrrole was obtained as a crude product.
在氢化钠(分散于60%液体石蜡,600mg,15mmol)与四氢呋喃(10mL)和二甲基咪唑啉酮(2mL)的悬浮液中在冰冷下滴加得到的2-(2-氟苯基)-1H-吡咯的粗产物的四氢呋喃(2mL)溶液并搅拌0.5小时。接下来滴加三异丙基甲硅烷基氯化物(3.2mL,15mmol)并在室温下搅拌2小时。在冷却至0℃的同时滴加水并用乙酸乙酯分液。在减压下馏去溶剂后,用庚烷和水再次进行分液操作,在减压下馏去溶剂,由此以粗产物的形式得到2-(2-氟苯基)-1-(三异丙基甲硅烷基)-1H-吡咯。The obtained 2-(2-fluorophenyl) was added dropwise to a suspension of sodium hydride (dispersed in 60% liquid paraffin, 600 mg, 15 mmol), tetrahydrofuran (10 mL) and dimethylimidazolidinone (2 mL) under ice cooling. A solution of the crude product of -1H-pyrrole in tetrahydrofuran (2 mL) was stirred for 0.5 hours. Next, triisopropylsilyl chloride (3.2 mL, 15 mmol) was added dropwise and stirred at room temperature for 2 hours. Water was added dropwise while cooling to 0°C, followed by liquid separation with ethyl acetate. After the solvent was distilled off under reduced pressure, the liquid separation operation was performed again with heptane and water, and the solvent was distilled off under reduced pressure to obtain 2-(2-fluorophenyl)-1-(trisine as a crude product. isopropylsilyl)-1H-pyrrole.
在得到的2-(2-氟苯基)-1-(三异丙基甲硅烷基)-1H-吡咯的粗产物的二氯甲烷(50mL)溶液中在冰冷下加入Vilsmeier试剂(3.8g,30mmol)并在40℃下搅拌0.5小时。在减压下馏去溶剂后,加入氢氧化钠水溶液(1.0M,100mL)并在室温下搅拌6小时,加入乙酸乙酯进行分液。将有机层用饱和食盐水进行清洗后,在减压下馏去溶剂。用庚烷和乙酸乙酯进行重结晶,在减压下进行干燥,由此得到标题化合物(1.34g,收率70%)。To a solution of the obtained crude product of 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole in dichloromethane (50 mL) was added Vilsmeier reagent (3.8 g, 30 mmol) and stirred at 40 °C for 0.5 h. After the solvent was distilled off under reduced pressure, an aqueous sodium hydroxide solution (1.0 M, 100 mL) was added, the mixture was stirred at room temperature for 6 hours, and ethyl acetate was added for liquid separation. After the organic layer was washed with saturated brine, the solvent was evaporated under reduced pressure. It was recrystallized from heptane and ethyl acetate, and dried under reduced pressure to obtain the title compound (1.34 g, yield 70%).
实施例5Example 5
5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-甲醛的制造Production of 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde
在氢化钠(分散于60%液体石蜡,32mg,0.79mmol)与四氢呋喃(2mL)的悬浮液中在冰冷下滴加5-(2-氟苯基)-1H-吡咯-3-甲醛(100mg,0.53mmol)的四氢呋喃(2mL)溶液并搅拌0.5小时后,加入15-冠-5-醚(0.16mL,0.79mmol)并在0℃下搅拌0.5小时。接下来,添加吡啶-3-磺酰氯(95μL,0.79mmol),在0℃搅拌0.5小时。进一步加入吡啶-3-磺酰氯(95μL,0.79mmol),在0℃搅拌0.5小时。滴加水并用乙酸乙酯分液。在水层中加入乙酸乙酯再次萃取后,将有机层合并并用饱和食盐水清洗。在减压下馏去溶剂后,用硅胶柱精制并在减压下干燥,由此得到标题化合物(167mg,收率95%)。To a suspension of sodium hydride (dispersed in 60% liquid paraffin, 32 mg, 0.79 mmol) and tetrahydrofuran (2 mL) was added dropwise 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde (100 mg, under ice-cooling) 0.53 mmol) in tetrahydrofuran (2 mL) and stirred for 0.5 h, 15-crown-5-ether (0.16 mL, 0.79 mmol) was added and stirred at 0°C for 0.5 h. Next, pyridine-3-sulfonyl chloride (95 μL, 0.79 mmol) was added, and the mixture was stirred at 0° C. for 0.5 hours. Further, pyridine-3-sulfonyl chloride (95 μL, 0.79 mmol) was added, and the mixture was stirred at 0° C. for 0.5 hours. Water was added dropwise and the mixture was separated with ethyl acetate. After adding ethyl acetate to the aqueous layer and extracting again, the organic layers were combined and washed with saturated brine. After the solvent was distilled off under reduced pressure, it was purified with a silica gel column and dried under reduced pressure to obtain the title compound (167 mg, yield 95%).
质谱(ESI):m/z calcd for C16H11FN2NaO3S「M+Na」+:353.04;found:353.00;1H-NMR(400MHz,CDCl3)δ(ppm):6.68(d,J=1.7Hz,1H),7.01-7.05(m,1H),7.16-7.18(m,2H),7.37-7.40(m,1H),7.45-7.51(m,1H),7.69-7.72(m,1H),8.15(d,J=1.8Hz,1H),8.58(d,J=1.7Hz,1H),8.82(dd,J=4.8,1.5Hz,1H),9.90(s,1H).Mass spectrum (ESI): m/z calcd for C16H11FN2NaO3S "M+Na"+: 353.04; found: 353.00; 1H-NMR (400MHz, CDCl3) δ (ppm): 6.68 (d, J=1.7Hz, 1H), 7.01 -7.05(m, 1H), 7.16-7.18(m, 2H), 7.37-7.40(m, 1H), 7.45-7.51(m, 1H), 7.69-7.72(m, 1H), 8.15(d, J= 1.8Hz, 1H), 8.58 (d, J=1.7Hz, 1H), 8.82 (dd, J=4.8, 1.5Hz, 1H), 9.90 (s, 1H).
实施例6Example 6
1-[5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-基]-N-甲基甲胺富马酸盐的制造Production of 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine fumarate
在5-(2-氟苯基)-1-(吡啶-3-基磺酰基)-1H-吡咯-3-甲醛(100mg,0.30mmol)的甲醇(3mL)溶液中在室温下滴加甲胺的甲醇溶液(2.0M,1.06mL,2.12mmol),搅拌0.5小时。冷却至0℃,加入硼氢化钠(34mg,0.91mmol)并搅拌0.5小时。在0℃滴加1当量盐酸(3mL),在室温下搅拌0.5小时。加入饱和碳酸氢钠水、乙酸乙酯进行分液。在水层中加入乙酸乙酯再次萃取后,将有机层合并并用饱和食盐水清洗。将有机层浓缩后,加入乙酸乙酯(3mL),添加富马酸(39mg,0.30mmol)的甲醇(0.3mL)溶液。在室温下搅拌30分钟后,过滤析出的晶体,用乙酸乙酯和甲醇清洗,得到粗产物。将得到的粗晶体由甲醇和水进行重结晶,过滤析出的晶体后,在减压下干燥,由此得到标题化合物(90mg,收率64%)。Methylamine was added dropwise to a solution of 5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3-carbaldehyde (100 mg, 0.30 mmol) in methanol (3 mL) at room temperature in methanol (2.0 M, 1.06 mL, 2.12 mmol) and stirred for 0.5 h. Cool to 0°C, add sodium borohydride (34 mg, 0.91 mmol) and stir for 0.5 h. 1 N hydrochloric acid (3 mL) was added dropwise at 0°C, and the mixture was stirred at room temperature for 0.5 hours. Saturated sodium bicarbonate water and ethyl acetate were added for liquid separation. After adding ethyl acetate to the aqueous layer and extracting again, the organic layers were combined and washed with saturated brine. After the organic layer was concentrated, ethyl acetate (3 mL) was added, and a solution of fumaric acid (39 mg, 0.30 mmol) in methanol (0.3 mL) was added. After stirring at room temperature for 30 minutes, the precipitated crystals were filtered and washed with ethyl acetate and methanol to obtain a crude product. The obtained crude crystals were recrystallized from methanol and water, and the precipitated crystals were filtered and dried under reduced pressure to obtain the title compound (90 mg, yield 64%).
质谱(ESI):m/z calcd for C17H17FN3NaO2S「M+H」+:346.09;found:346.11;1H-NMR(400MHz,DMSO-d6)δ(ppm):2.39(s,3H),3.76(s,2H),6.44(d,J=2.0Hz,1H),6.47(s,2H),7.10-7.13(m,1H),7.20-7.26(m,2H),7.50-7.56(m,1H),7.60-7.67(m,2H),7.85-7.89(m,1H),8.56(d,J=2.8Hz,1H),8.87-8.89(m,1H).3H未检出。Mass spectrum (ESI): m/z calcd for C17H17FN3NaO2S "M+H"+: 346.09; found: 346.11; 1H-NMR (400MHz, DMSO-d6) δ(ppm): 2.39(s, 3H), 3.76(s, 2H), 6.44(d, J=2.0Hz, 1H), 6.47(s, 2H), 7.10-7.13(m, 1H), 7.20-7.26(m, 2H), 7.50-7.56(m, 1H), 7.60 -7.67(m, 2H), 7.85-7.89(m, 1H), 8.56(d, J=2.8Hz, 1H), 8.87-8.89(m, 1H). 3H was not detected.
实施例7Example 7
5-(2-氟苯基)-1H-吡咯-3-甲醛的制造Production of 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde
在氢化钠(分散于60%液体石蜡,8.8g,220.0mmol)与4-甲基四氢吡喃(100mL)的悬浮液中在冰冷下滴加吡咯(15.7mL,220.0mmol)并搅拌0.5小时后,加入氯化锌(30.3g,220.0mmol)并在室温下搅拌0.5小时。接下来,加入乙酸钯(56.1mg,0.25mmol)、2-(二叔丁基膦基)联苯(74.6mg,0.25mmol)和1-氟-2-碘苯(11.5mL,100.0mmol),在约100℃搅拌1小时。在冰冷下,在反应混合物中滴加氢氧化钠水溶液(5.0N,220.0mmol),在室温下搅拌0.5小时。过滤不溶物,使用甲苯(100mL)清洗后,将有机层分离并使用甲苯(100mL)萃取水层。将有机层合并并用蒸馏水(167mL)和饱和食盐水(167mL)清洗。在减压下馏去溶剂后,在残渣中加入甲苯(167mL)。在减压下馏去溶剂,由此以粗产物(20.9g)的形式得到2-(2-氟苯基)-1H-吡咯。To a suspension of sodium hydride (dispersed in 60% liquid paraffin, 8.8 g, 220.0 mmol) and 4-methyltetrahydropyran (100 mL) was added dropwise pyrrole (15.7 mL, 220.0 mmol) under ice cooling and stirred for 0.5 h After that, zinc chloride (30.3 g, 220.0 mmol) was added and stirred at room temperature for 0.5 hour. Next, palladium acetate (56.1 mg, 0.25 mmol), 2-(di-tert-butylphosphino)biphenyl (74.6 mg, 0.25 mmol) and 1-fluoro-2-iodobenzene (11.5 mL, 100.0 mmol) were added, Stir at about 100°C for 1 hour. Under ice-cooling, an aqueous sodium hydroxide solution (5.0 N, 220.0 mmol) was added dropwise to the reaction mixture, followed by stirring at room temperature for 0.5 hour. The insoluble matter was filtered and washed with toluene (100 mL), the organic layer was separated, and the aqueous layer was extracted with toluene (100 mL). The organic layers were combined and washed with distilled water (167 mL) and saturated brine (167 mL). After the solvent was distilled off under reduced pressure, toluene (167 mL) was added to the residue. The solvent was distilled off under reduced pressure to obtain 2-(2-fluorophenyl)-1H-pyrrole as a crude product (20.9 g).
在氢化钠(分散于60%液体石蜡,4.4g,110.0mmol)与四氢呋喃(100mL)和二甲基咪唑啉酮(32.6mL,300.0mmol)的悬浮液中在冰冷下滴加得到的2-(2-氟苯基)-1H-吡咯的粗产物的四氢呋喃(10mL)溶液,用四氢呋喃(10mL)冲洗并搅拌0.5小时。接下来滴加三异丙基甲硅烷基氯化物(23.5mL,110.0mmol)并在室温下搅拌1小时。在冰浴下滴加蒸馏水(17mL),进一步加入蒸馏水(167mL)。使用乙酸乙酯(84mL)进行2次萃取,用蒸馏水(167mL)和饱和食盐水(167mL)清洗。在减压下馏去溶剂后,在残渣中加入甲苯(167mL)。在减压下馏去溶剂后,在减压下馏去溶剂,由此以粗产物(45.2g)的形式得到2-(2-氟苯基)-1-(三异丙基甲硅烷基)-1H-吡咯。To a suspension of sodium hydride (dispersed in 60% liquid paraffin, 4.4 g, 110.0 mmol), tetrahydrofuran (100 mL) and dimethylimidazolidinone (32.6 mL, 300.0 mmol) was added dropwise the resulting 2-( A solution of crude 2-fluorophenyl)-1H-pyrrole in tetrahydrofuran (10 mL), rinsed with tetrahydrofuran (10 mL) and stirred for 0.5 h. Next, triisopropylsilyl chloride (23.5 mL, 110.0 mmol) was added dropwise and stirred at room temperature for 1 hour. Distilled water (17 mL) was added dropwise under an ice bath, and distilled water (167 mL) was further added. Extraction was performed twice with ethyl acetate (84 mL), and washed with distilled water (167 mL) and saturated brine (167 mL). After the solvent was distilled off under reduced pressure, toluene (167 mL) was added to the residue. After the solvent was distilled off under reduced pressure, the solvent was distilled off under reduced pressure to obtain 2-(2-fluorophenyl)-1-(triisopropylsilyl) as a crude product (45.2 g). -1H-pyrrole.
在二氯甲烷(100mL)中加入草酰氯(17.2mL,200.0mmol),在冰冷下滴加DMF(15.5mL,200.0mmol),搅拌0.5小时。一次性加入得到的2-(2-氟苯基)-1-(三异丙基甲硅烷基)-1H-吡咯的粗产物的4-甲基四氢吡喃(100mL)溶液并在约50℃搅拌3小时。在冰冷下加入氢氧化钠水溶液(5.0M,100mL)并在室温下搅拌整夜。将有机层分离,将水层用乙酸乙酯(200mL)分液。将有机层合并,用饱和食盐水(200mL)清洗后,在减压下馏去溶剂。在得到的固体残渣中加入乙酸乙酯(47mL),在约70℃下溶解后,加入庚烷(300mL)。在室温下放冷后,在冰浴下搅拌1小时,滤取析出的晶体,用冷却的乙酸乙酯:庚烷(1:6,70mL)清洗。在减压下以50℃干燥1.5小时,由此得到标题化合物(13.6g,收率72%)。Oxalyl chloride (17.2 mL, 200.0 mmol) was added to dichloromethane (100 mL), DMF (15.5 mL, 200.0 mmol) was added dropwise under ice-cooling, and the mixture was stirred for 0.5 hour. A solution of the resulting crude 2-(2-fluorophenyl)-1-(triisopropylsilyl)-1H-pyrrole in 4-methyltetrahydropyran (100 mL) was added in one portion and heated at about 50 °C was stirred for 3 hours. Aqueous sodium hydroxide solution (5.0 M, 100 mL) was added under ice cooling and stirred at room temperature overnight. The organic layer was separated, and the aqueous layer was separated with ethyl acetate (200 mL). The organic layers were combined, washed with saturated brine (200 mL), and then the solvent was evaporated under reduced pressure. Ethyl acetate (47 mL) was added to the obtained solid residue, and after dissolving at about 70°C, heptane (300 mL) was added. After standing to cool at room temperature, the mixture was stirred in an ice bath for 1 hour, and the precipitated crystals were collected by filtration and washed with cooled ethyl acetate:heptane (1:6, 70 mL). It was dried at 50°C for 1.5 hours under reduced pressure, whereby the title compound (13.6 g, yield 72%) was obtained.
实施例8Example 8
5-(2-氟苯基)-1H-吡咯-3-甲醛的制造(由2-(2-氟苯基)-1H-吡咯的一锅合成)Production of 5-(2-fluorophenyl)-1H-pyrrole-3-carbaldehyde (one-pot synthesis from 2-(2-fluorophenyl)-1H-pyrrole)
在2-(2-氟苯基)-1H-吡咯(10.0g,62.0mmol)的4-甲基四氢吡喃(62mL)溶液中加入二甲基咪唑啉酮(20.0mL,186mmol)后,在冰冷下缓慢加入氢化钠(分散于60%液体石蜡,2.7g,68.2mmol)并搅拌10分钟。接下来,滴加三异丙基甲硅烷基氯化物(14.6mL,68.2mmol)并在冰冷下搅拌2小时。在由草酰氯(10.6mL,124mmol)和DMF(9.65mL,124mmol)制备的Vilsmeier试剂的二氯甲烷(90mL)溶液中在冰冷下一次性加入2-(2-氟苯基)-1H-吡咯的反应溶液,用4-甲基四氢吡喃(20mL)冲洗,在约60℃搅拌2小时。在冰冷下加入氢氧化钠水溶液(2.0M,310mL)并在室温下搅拌整夜。将有机层分离,将水层用乙酸乙酯(120mL)分液。将有机层合并,用饱和食盐水(120mL)清洗后,在减压下馏去溶剂。在得到的固体残渣中加入乙酸乙酯(29mL),在约70℃溶解后,加入庚烷(180mL)。在室温下放冷后,在冰浴下搅拌1小时,滤取析出的晶体,用冷却的乙酸乙酯:庚烷(1:6,42mL)清洗。在减压下以50℃干燥1.5小时,由此得到标题化合物(8.30g,收率71%)。After adding dimethylimidazolidinone (20.0 mL, 186 mmol) to a solution of 2-(2-fluorophenyl)-1H-pyrrole (10.0 g, 62.0 mmol) in 4-methyltetrahydropyran (62 mL), Sodium hydride (dispersed in 60% liquid paraffin, 2.7 g, 68.2 mmol) was slowly added under ice-cooling and stirred for 10 minutes. Next, triisopropylsilyl chloride (14.6 mL, 68.2 mmol) was added dropwise and stirred under ice-cooling for 2 hours. To a solution of Vilsmeier's reagent in dichloromethane (90 mL) prepared from oxalyl chloride (10.6 mL, 124 mmol) and DMF (9.65 mL, 124 mmol) was added 2-(2-fluorophenyl)-1H-pyrrole in one portion under ice cooling The resulting reaction solution was rinsed with 4-methyltetrahydropyran (20 mL) and stirred at about 60° C. for 2 hours. Aqueous sodium hydroxide solution (2.0 M, 310 mL) was added under ice cooling and stirred at room temperature overnight. The organic layer was separated, and the aqueous layer was separated with ethyl acetate (120 mL). The organic layers were combined, washed with saturated brine (120 mL), and then the solvent was evaporated under reduced pressure. Ethyl acetate (29 mL) was added to the obtained solid residue, and after dissolving at about 70°C, heptane (180 mL) was added. After standing to cool at room temperature, the mixture was stirred in an ice bath for 1 hour, and the precipitated crystals were collected by filtration and washed with cooled ethyl acetate:heptane (1:6, 42 mL). It was dried at 50°C for 1.5 hours under reduced pressure, whereby the title compound (8.30 g, yield 71%) was obtained.
Claims (7)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017-251749 | 2017-12-27 | ||
JP2017251749 | 2017-12-27 | ||
PCT/JP2018/047697 WO2019131695A1 (en) | 2017-12-27 | 2018-12-26 | Production method for 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1h-pyrrol-3-yl]-n-methylmethanamine monofumarate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111527067A true CN111527067A (en) | 2020-08-11 |
CN111527067B CN111527067B (en) | 2024-06-25 |
Family
ID=67063705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201880082979.8A Active CN111527067B (en) | 2017-12-27 | 2018-12-26 | Process for the preparation of 1- [5- (2-fluorophenyl) -1- (pyridin-3-ylsulfonyl) -1H-pyrrol-3-yl ] -N-methylmethylamine monofumarate |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7227925B2 (en) |
KR (2) | KR102443292B1 (en) |
CN (1) | CN111527067B (en) |
WO (1) | WO2019131695A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114573560A (en) * | 2022-03-17 | 2022-06-03 | 日照正济药业有限公司 | Preparation method of Voranolan fumarate |
CN116514698A (en) * | 2023-04-10 | 2023-08-01 | 佛山奕安赛医药科技有限公司 | Preparation method and application of voronoi intermediate |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113549054B (en) * | 2020-04-23 | 2024-03-15 | 鲁南制药集团股份有限公司 | Vonoprazan fumarate intermediate and preparation method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106187852A (en) * | 2016-07-07 | 2016-12-07 | 江西同和药业股份有限公司 | A kind of preparation method of Vonoprazan fumarate intermediate |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5819494B2 (en) | 1978-11-06 | 1983-04-18 | トヨタ自動車株式会社 | Passive seat belt device |
IL87222A (en) * | 1987-07-29 | 1993-04-04 | American Cyanamid Co | Arylpyrroles, methods for thepreparation thereof andinsecticidal, acaricidal andnematicidal compositionscontaining them |
US5101042A (en) | 1990-12-11 | 1992-03-31 | American Cyanamid Company | Process for the preparation of insecticidal, nematicidal and acaricidal 2-halo-3-substituted-5-arylpyrrole compounds |
HRP20110473T1 (en) * | 2005-08-30 | 2011-07-31 | Takeda Pharmaceutical Company Limited | 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors |
KR101724293B1 (en) * | 2009-02-25 | 2017-04-07 | 다케다 야쿠힌 고교 가부시키가이샤 | Process for producing pyrrole compound |
CN105440019A (en) * | 2015-12-17 | 2016-03-30 | 昆明贵研药业有限公司 | A kind of preparation method of medicine for treating gastric acid disease |
CN108191830B (en) * | 2016-06-30 | 2019-06-14 | 珠海赛隆药业股份有限公司(长沙)医药研发中心 | A kind of Vonoprazan fumarate intermediate IV and preparation method thereof |
CN106366071B (en) * | 2016-08-22 | 2019-05-07 | 山东金城医药集团股份有限公司 | The preparation method of Vonoprazan fumarate |
-
2018
- 2018-12-26 KR KR1020207019383A patent/KR102443292B1/en active Active
- 2018-12-26 KR KR1020227030825A patent/KR102500124B1/en active Active
- 2018-12-26 WO PCT/JP2018/047697 patent/WO2019131695A1/en active Application Filing
- 2018-12-26 CN CN201880082979.8A patent/CN111527067B/en active Active
- 2018-12-26 JP JP2019562062A patent/JP7227925B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106187852A (en) * | 2016-07-07 | 2016-12-07 | 江西同和药业股份有限公司 | A kind of preparation method of Vonoprazan fumarate intermediate |
Non-Patent Citations (2)
Title |
---|
FARNAZ JAFARPOU ET AL.: ""Triethanolamine-Mediated Palladium-Catalyzed Regioselective C-2 Direct Arylation of Free NH-Pyrroles"", 《J. ORG. CHEM.》, vol. 75, pages 3109 - 3112 * |
YASUYOSHI ARIKAWA ET AL.: ""Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (PCAB)"", 《J. MED. CHEM.》, vol. 55, pages 4446 - 4456 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114573560A (en) * | 2022-03-17 | 2022-06-03 | 日照正济药业有限公司 | Preparation method of Voranolan fumarate |
CN114573560B (en) * | 2022-03-17 | 2024-02-06 | 日照正济药业有限公司 | Preparation method of voronoi fumarate |
CN116514698A (en) * | 2023-04-10 | 2023-08-01 | 佛山奕安赛医药科技有限公司 | Preparation method and application of voronoi intermediate |
Also Published As
Publication number | Publication date |
---|---|
KR102443292B1 (en) | 2022-09-14 |
KR102500124B1 (en) | 2023-02-14 |
JPWO2019131695A1 (en) | 2021-01-14 |
JP7227925B2 (en) | 2023-02-22 |
CN111527067B (en) | 2024-06-25 |
KR20200096598A (en) | 2020-08-12 |
WO2019131695A1 (en) | 2019-07-04 |
KR20220127369A (en) | 2022-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8440831B2 (en) | Process and intermediates for preparing integrase inhibitors | |
WO1999001420A1 (en) | Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process | |
JP7547622B2 (en) | Method for preparing (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide and intermediates | |
CN111527067A (en) | Method for producing 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethylamine monofumarate | |
CN115803318A (en) | Process for the preparation of (5S) -5- ({ 2- [4- (butoxycarbonyl) phenyl ] ethyl } [2- (2- { [ 3-chloro-4' - (trifluoromethyl) [ biphenyl ] -4-yl ] methoxy } phenyl) ethyl ] amino) -5,6,7,8-tetrahydroquinoline-2-carboxylic acid butyl ester | |
JP2000063334A (en) | Novel intermediate for the production of enyne derivatives and its production method | |
CN111051289A (en) | Process for producing protected L-carnosine derivatives, L-carnosine and crystalline L-carnosine zinc complexes | |
JP7497357B2 (en) | Process for the preparation of 1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]-3-[(2-fluoro-6-methoxy-4-pyridyl)amino]pyrazole-4-carboxamide | |
CN102414169B (en) | Process for preparing carboxylic acid amides useful in the treatment of muscular disorders | |
CN113754544B (en) | Preparation method of polysubstituted (E) -trifluoromethyl olefin | |
CN113861167A (en) | Preparation method of Voranolan fumarate | |
CN112272665B (en) | Process for preparing ritalst | |
CN114929680B (en) | Process for preparing chroman compounds | |
JP4258658B2 (en) | Method for producing acetylene compound | |
CN111556861A (en) | Preparation method of jasmonate compound | |
CN112142710B (en) | Method for producing ester compound | |
JP7424115B2 (en) | Method for producing ester compounds | |
Richards | New Methods for the Synthesis of Novel Triazoles as Ligands and Potential Drugs | |
JP2022035954A (en) | N-Boc-lactam derivative and its production method, and cyclic amine derivative production method. | |
JP4000758B2 (en) | Process for producing 2- (5-halogeno-2-nitrophenyl) -2-substituted acetate derivative | |
WO2005063678A1 (en) | Process for producing phenylacetic acid derivative | |
CN119371481A (en) | Method for photocatalytic synthesis of N-(trifluoromethylthio)phenylglycine derivatives/N-(trifluoromethylthio)dipeptide compounds | |
TW202419441A (en) | Method for producing alkylsilyloxy-substituted benzylamine compound | |
CN118108572A (en) | A method for synthesizing alkyl trifluoromethyl compounds | |
CN1290247A (en) | Process and intermediates for the preparation of antifolates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |